112160-84-6 | (2S,3S,4S,5S,6R)-6-[(tert-butylamino)methyl]-5-(2-cyclopentyl-4-hydroxyphenoxy)-6-ethoxy-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (non-preferred name) | C24H37 N O9 |
112160-86-8 | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3-cyclopentylphenyl hydrogen sulfate | C18H29 N O6 S |
112160-85-7 | (2S,3S,4S,5S,6R)-6-[(tert-butylamino)methyl]-5-[2-(cyclopent-1-en-1-yl)phenoxy]-6-ethoxy-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (non-preferred name) | C24H35 N O8 |
112160-82-4 | PREPRO-ATRIAL NATRIURETIC FACTOR (26-55) (HUMAN) | C152H236 N38 O51 S3 |
112160-83-5 | KALIURETIC PEPTIDE (HUMAN) | C94H171 N31 O28 |
112160-96-0 | vasoactive intestinal peptide (1-12) | C62H90 N18 O22 |
112160-37-9 | H-ARG(PMC)-OH | C20H32 N4 O5 S |
112160-33-5 | Z-ARG(PMC)-OH CHA | C34H51N5O7S |
112160-02-8 | 1H-1,4-Benzodiazepinium, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1,4-bis(2-hydroxyethyl)-2-oxo-, chloride | C19H19ClFN2O3.Cl |
112160-40-4 | Phosphoric acid, 2-[[bis(1-methylethoxy)phosphinyl]amino]ethyl bis(1-methylethyl) ester | C14H33NO7P2 |
112160-54-0 | L-Glutamic acid, N-[N-[N-[N-[N-[N-(N-L-a-glutamyl-L-seryl)-L-leucyl]-L-seryl]-L-seryl]-L-seryl ]-L-a-glutamyl]-, mono(trifluoroacetate) (salt) | C33H54N8O19.C2HF3O2 |
112160-87-9 | PENBUTOLOL IMPURITY A | C18H27NO2 |